Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) stock cut his price target on the pharmaceutical giant. Even though that ...

Eli Lilly is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so.Trading at $852 per share, LLY ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock stand now. The GLP-1 agonist opportunity is gearing up for its next ...

Eli White has impressed with his bat and glove — and Braves fans already have a bold idea for how he could stick around when Ronald Acuña Jr. comes back. When Ronald Acuña Jr. returns from his ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Tom Brady's playful rivalry with Eli Manning reignited after a viral video showed Brady joking about never losing to Manning, referencing their Super Bowl clashes. Giants fans swiftly responded ...

Giants fans surely don’t look back on cornerback Eli Apple’s tenure with New York very fondly. The 10th overall pick in the 2016 NFL Draft, solidly known as a draft bust amongst Giants fans ...

The Houston Texans added Kentucky IOL Eli Cox as an undrafted free agent after the 2025 NFL draft. Eli Cox is a four-year starting center and right guard under four different offensive ...

OXFORD — The New York Giants have given Ole Miss football quarterback Jaxson Dart a chance to break more of Eli Manning's records. The Giants selected Dart with the No. 25 pick in the first ...

Daven Wu is the Singapore Editor at Wallpaper*. A former corporate lawyer, he has been covering Singapore and the neighbouring South-East Asian region since 1999, writing extensively about ...

Atria is a Dividend King with an impressive track record for dividend growth. Eli Lilly has been raising its dividend at a more impressive pace than Altria in recent years. Altria has an ...